top of page
042024_pharmawrite_background_transparent.png

WritePharma Publishing

Open Submission | Eligibility Requirements

To submit an article to WritePharma, all authors, editors, and named participants must hold a Doctor of Pharmacy (PharmD) or an equivalent degree that is recognized and in good standing within the United States.

 

Pharmacists must have graduated from an accredited school of pharmacy or be currently enrolled as a student in an accredited program. Submissions require English proficiency and a strong understanding of research methodology, medical writing, clinical analysis, and biopharmaceutics. A doctoral-level education or foreign equivalent is mandatory to ensure the highest standards of scientific integrity and expertise.

J Scrip Pharm

URL

ISSN

e-ISSN: 3064-9412

p-ISSN: 3064-9404

Date of First Publication

October 2024

A modern, pharmacotherapy-focused scientific journal focusing primarily on the production of complete reviews re. breakthrough pharmacotherapies, specifically those of speciality pharmaceutical facilities and which fill a gap in therapy not otherwise met with FDA-approved therapies.

These articles are available with a J Scrip Pharm subscription.  Abstract available free to the public only.  DOI Registration & Metadata Maintenance Included.

URL

Date of First Publication

February 2024

Open-access, public-focused pharmacotherapeutic news, updates, and commentary articles.  These articles are available free to the public.  DOI Registration & Metadata Maintenance Included.

bottom of page